SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-006526
Filing Date
2018-05-10
Accepted
2018-05-10 08:30:15
Documents
16
Period of Report
2018-05-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 28860
2 ex99-1.htm EX-99.1 12885
3 ex99-2.htm EX-99.2 36091
4 image_001.jpg GRAPHIC 52902
5 image_002.jpg GRAPHIC 104456
6 image_003.jpg GRAPHIC 61231
7 image_004.jpg GRAPHIC 76652
8 image_005.jpg GRAPHIC 81346
9 image_006.jpg GRAPHIC 53253
10 image_007.jpg GRAPHIC 64993
11 image_008.jpg GRAPHIC 53765
12 image_009.jpg GRAPHIC 91128
13 image_010.jpg GRAPHIC 72940
14 image_011.jpg GRAPHIC 39719
15 ex99-2_001.jpg GRAPHIC 5390
16 ex99-2_002.jpg GRAPHIC 5304
  Complete submission text file 0001493152-18-006526.txt   1131569
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 18820640
SIC: 2834 Pharmaceutical Preparations